Company Filing History:
Years Active: 2017-2018
Title: Petra Rengers: Innovator in Neuromyelitis Optica Diagnosis
Introduction
Petra Rengers is a notable inventor based in Münster, Germany. She has made significant contributions to the field of medical diagnostics, particularly in the diagnosis of neuromyelitis optica. With a total of 2 patents, her work is paving the way for advancements in this critical area of healthcare.
Latest Patents
One of Petra Rengers' latest patents is a method for the diagnosis and/or risk stratification of neuromyelitis optica (NMO). This invention involves determining the presence of artificial aquaporin-4 peptides from a body sample of a patient or test subject. Additionally, the invention includes a kit and new artificial aquaporin-4 peptides, which are essential for the diagnostic process.
Career Highlights
Petra Rengers is currently associated with Protagen AG, where she continues to innovate and contribute to medical research. Her expertise in the field has led to the development of groundbreaking methods that enhance the understanding and diagnosis of neuromyelitis optica.
Collaborations
Throughout her career, Petra has collaborated with esteemed colleagues such as Heike Göhler and Angelika Lüking. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Petra Rengers is a pioneering inventor whose work in the diagnosis of neuromyelitis optica is making a significant impact in the medical field. Her contributions are vital for advancing diagnostic methods and improving patient outcomes.